Mohammadzadeh Boukani, L., Valizadeh, A., Golchin, A., Molavand, M., Vaghari-Tabari, M. & Yousefi, B. (2026). Ellagic Acid May Potentiate Doxorubicin Efficacy in Osteosarcoma Cells through Dual Apoptotic Activation and P-glycoprotein Suppression. (e742541). Iranian Biomedical Journal, (), e742541

Mohammadzadeh Boukani, L., Valizadeh, A., Golchin, A., Molavand, M., Vaghari-Tabari, M., & Yousefi, B. "Ellagic Acid May Potentiate Doxorubicin Efficacy in Osteosarcoma Cells through Dual Apoptotic Activation and P-glycoprotein Suppression" .e742541 , Iranian Biomedical Journal, , 2026, e742541.

Mohammadzadeh Boukani L., Valizadeh A., Golchin A., Molavand M., Vaghari-Tabari M., Yousefi B. (2026). 'Ellagic Acid May Potentiate Doxorubicin Efficacy in Osteosarcoma Cells through Dual Apoptotic Activation and P-glycoprotein Suppression', Iranian Biomedical Journal, (), e742541.

L. Mohammadzadeh Boukani, A. Valizadeh, A. Golchin, M. Molavand, M. Vaghari-Tabari & B. Yousefi, "Ellagic Acid May Potentiate Doxorubicin Efficacy in Osteosarcoma Cells through Dual Apoptotic Activation and P-glycoprotein Suppression," Iranian Biomedical Journal, (2026): e742541,

Mohammadzadeh Boukani L., Valizadeh A., Golchin A., Molavand M., Vaghari-Tabari M., Yousefi B. Ellagic Acid May Potentiate Doxorubicin Efficacy in Osteosarcoma Cells through Dual Apoptotic Activation and P-glycoprotein Suppression. Iranian Biomedical Journal. 2026;():e742541.